Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 21;12(1):12457.
doi: 10.1038/s41598-022-16661-x.

Improving genetic diagnosis by disease-specific, ACMG/AMP variant interpretation guidelines for hearing loss

Affiliations

Improving genetic diagnosis by disease-specific, ACMG/AMP variant interpretation guidelines for hearing loss

So Young Kim et al. Sci Rep. .

Abstract

The 2018 Hearing Loss Expert Panel (HL-EP)-specific guidelines specified from the universal 2015 ACMG/AMP guidelines are proposed to be used in genetic HL, which prompted this study. A genetic HL cohort comprising 135 unrelated probands with available exome sequencing data was established. Overall, 169 variants were prioritized as candidates and interpreted using the 2015 ACMG/AMP and 2018 HL-EP guidelines. Changes in rule application and variant classification between the guidelines were compared. The concordance rate of variant classification of each variant between the guidelines was 71.60%, with significant difference. The proportion of pathogenic variants increased from 13.02% (2015) to 29.59% (2018). Variant classifications of autosomal recessive (AR) variants that previously belonged to VUS or likely pathogenic in the 2015 guidelines were changed toward pathogenic in the 2018 guidelines more frequently than those of autosomal dominant variants (29.17% vs. 6.38%, P = 0.005). Stratification of the PM3 and PP1 rules in the 2018 guidelines led to more substantial escalation than that in the 2015 guidelines. We compared the disease-specific guidelines (2018) with the universal guidelines (2015) using real-world data. Owing to the sophistication of case-level data, the HL-specific guidelines have more explicitly classified AR variants toward "likely pathogenic" or "pathogenic", serving as potential references for other recessive genetic diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The study design of the present study. The 169 variants of 135 genetically unrelated sensorineural hearing loss probands were classified based on the 2015 ACMG/AMP and 2018 HL-EP guidelines. The variants classification between the 2015 ACMG/AMP and 2018 HL-EP guidelines were compared.
Figure 2
Figure 2
Comparison of Bayesian values between the 2015 ACMG/AMP and 2018 HL-EP guidelines.
Figure 3
Figure 3
Frequency of criteria applied in the 2015 ACMG/AMP and 2018 HL-EP guidelines. The most commonly applied rule in the two guidelines was PM2 and the criterion of PM3 yielded the most drastic difference between the 2015 ACMG/AMP and 2018 HL-EP guidelines.

Similar articles

Cited by

References

    1. Lin X, et al. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. Hear Res. 2012;288:67–76. doi: 10.1016/j.heares.2012.01.004. - DOI - PMC - PubMed
    1. Kim BJ, et al. Targeted exome sequencing of deafness genes after failure of auditory phenotype-driven candidate gene screening. Otol. Neurotol. 2015;36:1096–1102. doi: 10.1097/MAO.0000000000000747. - DOI - PubMed
    1. Oh DY, Choi BY. Genetic information and precision medicine in hearing loss. Clin. Exp. Otorhinolaryngol. 2020;13:315–317. doi: 10.21053/ceo.2020.01606. - DOI - PMC - PubMed
    1. Eisenberger T, et al. Targeted and genomewide NGS data disqualify mutations in MYO1A, the "DFNA48 gene", as a cause of deafness. Hum. Mutat. 2014;35:565–570. doi: 10.1002/humu.22532. - DOI - PubMed
    1. Richards S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed

Publication types